July 7, 2025
BCS is very happy to announce that Morgan Hill, CA based Duke Empirical (DUKE) has been acquired by TEAM Technologies Inc., headquartered in TN.
Congratulations to Duke Founder Rob LaDuca, as well as TEAM Technologies on the acquisition. This is a special one for BCS to announce having been a longtime advisor to Rob and Duke. BCS also acted as advisors to TEAM technologies on this deal.
This is a strategic acquisition for TEAM as they add the structural heart, interventional and neurovascular markets with high end catheter manufacturing, delivery systems and precision extrusion capabilities to their growing platform.
No terms of the deal were announced at this time.
Boston based, Medtech Investment Banker, Covington Associates acted as M&A advisors to Duke Empirical.
Private equity and PE backed companies continue to be extremely active in the MedTech and life sciences contract manufacturing and services industry.
As we enter the second half of 2025, it looks like the bolt on and tuck in acquisitions will continue at a brisk pace. Buckle up!
++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
From TEAM’s press release:
Based in Morgan Hill, CA, Duke is recognized for its deep technical expertise and innovation in catheter design, complex medical extrusion, and high precision assembly. The company serves top-tier global OEMs with a differentiated suite of capabilities, proprietary technologies, and a state-of-the-art facility. Specifically, Duke manufactures a variety of catheters, including those used for minimally invasive structural heart, cardiovascular, neurovascular, urology and kidney-related procedures, while offering custom design and development services for catheter-based medical devices including guide catheters, balloon dilation catheters, and ultrasound catheters.
Headquartered in Knoxville, TN, with ISO 13485 facilities throughout the United States and international facilities in Mexico and Singapore, TEAM Technologies is a specialized end-to-end outsourced manufacturer of mission-critical, single-use medical devices. The company has an extensive array of advanced and vertically integrated manufacturing solutions servicing top medical device and pharmaceutical OEMs.
“This is a pivotal step in our strategy to become the full-service partner of choice for healthcare OEMs in high-growth, high-acuity end markets,” commented Marshall White, President and CEO of TEAM Tech. “With Duke’s complementary capabilities and innovative solutions, we are expanding the breadth and depth of services we offer to our partners while advancing our mission of Helping Those Who Help Others.”
Duke’s devices play a critical role in minimally invasive procedures, particularly in interventional and structural heart applications. Its advanced catheter systems, including custom and steerable designs, enable clinicians to navigate complexity and deliver therapies with precision in high-risk cardiovascular interventions. These mission-critical components improve access, efficiency, and outcomes in life-saving procedures, making Duke’s technologies foundational to the development of next-generation therapies.
“We’re thrilled to bring our expertise in minimally invasive device design, development and manufacturing to TEAM’s platform,” said Robert LaDuca, Duke’s Founder and CEO. “This partnership gives us the scale, talent, and infrastructure to continue driving innovation and improve outcomes for patients worldwide.”
